IL160029A0 - Receptor, the use thereof, and mouse antibodies - Google Patents

Receptor, the use thereof, and mouse antibodies

Info

Publication number
IL160029A0
IL160029A0 IL16002902A IL16002902A IL160029A0 IL 160029 A0 IL160029 A0 IL 160029A0 IL 16002902 A IL16002902 A IL 16002902A IL 16002902 A IL16002902 A IL 16002902A IL 160029 A0 IL160029 A0 IL 160029A0
Authority
IL
Israel
Prior art keywords
receptor
determinant
mouse antibodies
murine antibody
antibody
Prior art date
Application number
IL16002902A
Other languages
English (en)
Inventor
Hans-Konrad Muller-Hermelink
Heinz Vollmers
Frank Hensel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2001136009 external-priority patent/DE10136009A1/de
Priority claimed from DE2002110425 external-priority patent/DE10210425A1/de
Application filed filed Critical
Publication of IL160029A0 publication Critical patent/IL160029A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL16002902A 2001-07-24 2002-07-23 Receptor, the use thereof, and mouse antibodies IL160029A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2001136009 DE10136009A1 (de) 2001-07-24 2001-07-24 Rezeptor, dessen Verwendung sowie Mausantikörper
DE2002110425 DE10210425A1 (de) 2002-03-09 2002-03-09 Rezeptor, dessen Verwendung sowie Mausantikörper
PCT/DE2002/002699 WO2003011907A2 (de) 2001-07-24 2002-07-23 Rezeptor, dessen verwendung sowie mausantikörper

Publications (1)

Publication Number Publication Date
IL160029A0 true IL160029A0 (en) 2004-06-20

Family

ID=26009767

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16002902A IL160029A0 (en) 2001-07-24 2002-07-23 Receptor, the use thereof, and mouse antibodies
IL160029A IL160029A (en) 2001-07-24 2004-01-23 Purified polypeptides that bind a human adenocarcinoma cell line

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL160029A IL160029A (en) 2001-07-24 2004-01-23 Purified polypeptides that bind a human adenocarcinoma cell line

Country Status (11)

Country Link
US (2) US7378247B2 (zh)
EP (2) EP1423425B1 (zh)
JP (1) JP4344237B2 (zh)
CN (2) CN1558914A (zh)
AT (1) ATE490271T1 (zh)
AU (1) AU2002325164B2 (zh)
CA (1) CA2455154A1 (zh)
DE (1) DE50214797D1 (zh)
IL (2) IL160029A0 (zh)
RU (1) RU2004105599A (zh)
WO (1) WO2003011907A2 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL160029A0 (en) 2001-07-24 2004-06-20 Receptor, the use thereof, and mouse antibodies
EP2322559A3 (en) 2002-07-04 2011-08-03 Patrys Limited Neoplasm specific antibodies and uses thereof
DE10311248A1 (de) 2003-03-14 2004-09-30 Müller-Hermelink, Hans Konrad, Prof. Dr. Humaner monoklonaler Antikörper
EP1531162A1 (en) 2003-11-14 2005-05-18 Heinz Vollmers Adenocarcinoma specific antibody SAM-6, and uses thereof
DE10353175A1 (de) 2003-11-14 2005-06-16 Müller-Hermelink, Hans Konrad, Prof. Dr. Humaner monoklonaler Antikörper mit fettsenkender Wirkung
US20090029460A1 (en) * 2004-01-26 2009-01-29 Peter Vollmers Neoplasm-specific polypeptides and their uses
CA2553826A1 (en) * 2004-01-26 2005-12-08 Debiovision Inc. Neoplasm-specific polypeptides and their uses
DE102004015179A1 (de) * 2004-03-25 2005-10-13 Oncomab Gmbh Antigen des PM-2 Antikörpers und dessen Verwendung
WO2012087913A2 (en) * 2010-12-20 2012-06-28 The Regents Of The University Of Michigan Peptide reagents and methods for detection of colon dysplasia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US5618920A (en) * 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
US6020145A (en) * 1989-06-30 2000-02-01 Bristol-Myers Squibb Company Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
GB9323648D0 (en) * 1992-11-23 1994-01-05 Zeneca Ltd Proteins
AU733898B2 (en) * 1997-03-05 2001-05-31 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Immunotoxins and methods of inducing immune tolerance
ES2219108T3 (es) 1998-12-22 2004-11-16 Heinz Peter Vollmers Sustancia para producir medicamentos antitumorales altamente eficaces y su metodo correspondiente.
IL160029A0 (en) * 2001-07-24 2004-06-20 Receptor, the use thereof, and mouse antibodies
DE10210427A1 (de) 2002-03-09 2003-10-09 Hans Konrad Mueller-Hermelink Humaner monoklonaler Antikörper
EP2322559A3 (en) 2002-07-04 2011-08-03 Patrys Limited Neoplasm specific antibodies and uses thereof

Also Published As

Publication number Publication date
US20090136420A1 (en) 2009-05-28
JP2005508884A (ja) 2005-04-07
WO2003011907A2 (de) 2003-02-13
US20050032134A1 (en) 2005-02-10
IL160029A (en) 2010-04-15
JP4344237B2 (ja) 2009-10-14
WO2003011907A3 (de) 2003-10-16
EP1423425A2 (de) 2004-06-02
US7378247B2 (en) 2008-05-27
DE50214797D1 (de) 2011-01-13
RU2004105599A (ru) 2005-07-27
EP1423425B1 (de) 2010-12-01
CA2455154A1 (en) 2003-02-13
CN101812133A (zh) 2010-08-25
CN1558914A (zh) 2004-12-29
EP2348045A1 (de) 2011-07-27
ATE490271T1 (de) 2010-12-15
AU2002325164B2 (en) 2008-12-04

Similar Documents

Publication Publication Date Title
DK1531850T3 (da) Anvendelse af 1L-21 og monoklonalt antistof til behandling af solide cancere
PT1157042E (pt) Produção de anticorpos tetravalentes
ATE226641T1 (de) Humaner 4-1bb spezifischer humaner antikörper und diesen produzierende zellinie
DK0626447T3 (da) Monoklonale antistoffer og Fv, som er specifikke for CD2-antigen
WO1998018826A3 (en) Anti-CCR5 antibodies and methods of use therefor
EP1329459A3 (en) Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
AU3327701A (en) Humanized anti-ccr2 antibodies and methods of use therefor
UA41888C2 (uk) Злитий білок, який складається з мишачого або олюдненого моноклонального антитіла мав425 або його фрагменту, який спрямовано проти пухлинної клітини, спосіб його отримання, фармацевтична композиція
WO2003072736A3 (en) Reagents and treatment methods for autoimmune diseases
MXPA03005273A (es) Anticuerpos producidos procarioticamente y sus usos.
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
HUP0402192A2 (hu) EGF receptor elleni antitesteket tartalmazó liofilizált készítmény
IL160029A0 (en) Receptor, the use thereof, and mouse antibodies
IL144265A0 (en) Use of antibodies for the vaccination against cancer
PT1331944E (pt) Utilização de anticorpos monoclonais específicos para cd28 para a estimulação de células sanguíneas que não comportam qualquer cd28
IL139852A0 (en) Monoclonal antibodies directed against the g3bp protein, and uses
AU2003263294A1 (en) Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor
EP2641611A3 (en) Combination therapy
EP0990703A4 (en) NEW POLYPEPTIDE, FOR CODING DNA AND THEIR USE
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
AR010333A1 (es) Una muteina ob, una secuencia de adn, un vector de expresion una celula hospedadora procariota o de mamifero, un baculovirus recombinante, una celulahospedadora, un metodo para la produccion de una muteina ob, una composicion farmaceutica, el uso de una proteina ob para la preparacion de una composi
DK0672685T3 (da) Monoklonalt antistof specifik for tumor cytotoxisk faktor (TCF-11)
AU6442000A (en) Novel nicotinic acetylcholine receptor subunit, its isolation and use
DK31589A (da) Assay for begyndende diabetes, monoklonale antistoffer til anvendelse herved og saet til anvendelse hertil.
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse